HIGHLIGHTS
- What: Through this investigation, the authors aimed to elucidate the immunomodulatory mechanisms of gut microbiota and provide insights for the development of novel therapeutic approaches for AD patients.
- Who: Huachang Zhang from the Shahid Beheshti University of Medical Sciences, Iran have published the article: The involvement of effector memory CD4+ T cells in mediating the impact of genus Oscillibacter gut microbiota on Alzheimer’s disease: a Mendelian randomization study, in the Journal: (JOURNAL)
- How: The authors used a two-step Mendelian Randomization approach to analyze the causal relationships between 412 gut microbiota species . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.